Roche has obtained a CE mark for its cobas SARS-CoV-2 Qualitative test to identify the virus using saliva samples on the cobas 6800/8800 Systems. The test is indicated for use in asymptomatic people and those who are suspected of Covid-19. The non-invasive test is offered as a self-collect test, where users can obtain saliva samples on-site under the supervision of healthcare specialists. Apart from testing with saliva samples, the test is approved for use with nasal, nasopharyngeal, and oropharyngeal swab specimens to identify infection including those caused by the Omicron variant.
